Non-alcoholic fatty liver disease (NAFLD) has become one of the most frequent chronic liver
diseases in the Western society and its prevalence is likely to rise even further. An …

Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial
pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an …

Nonalcoholic fatty liver disease (NAFLD) is a common, progressive liver disease that affects
up to one-quarter of the adult population worldwide. The clinical and economic burden of …

Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population worldwide
and may confer increased cardiometabolic risk with consequent adverse cardiovascular …

Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are obesity‐related
conditions with high cardiovascular mortality. Whether NAFLD is independently associated …

Although there is an established bidirectional relationship between heart failure with
reduced ejection fraction and liver disease, the association between heart failure with …

Non-alcoholic fatty liver disease (NAFLD) has emerged as a public health problem of
epidemic proportions worldwide. Accumulating clinical and epidemiological evidence …

The first clinical application of magnetic resonance elastography (MRE) was in the
evaluation of chronic liver disease (CLD) for detection and staging of liver fibrosis. In the …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease.
NAFLD includes a wide spectrum of liver conditions ranging from simple steatosis to …

OBJECTIVE Data on cardiac function in patients with nonalcoholic fatty liver disease
(NAFLD) are limited and conflicting. We assessed whether NAFLD is associated with …